SEC Info - Cigna Corp - ‘8-K’ for 2/6/20

SEC Info℠

Home

Help

Please Sign In

Cigna Corp – ‘8-K’ for 2/6/20

On: Thursday, 2/6/20, at 6:15am ET · For: 2/6/20 · Accession #: 950159-20-34 · File #: 1-38769

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/06/20  Cigna Corp                        8-K:2,9     2/06/20   11:435K                                   Scullin Group, Inc./FA

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Cigna Corporation Form 8-K                          HTML     29K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    130K 
 7: R1          Cover                                               HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 9: XML         XBRL Instance -- cigna8k_htm                         XML     14K 
 6: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- ci-20200206_lab                       XML     96K 
 5: EX-101.PRE  XBRL Presentations -- ci-20200206_pre                XML     64K 
 3: EX-101.SCH  XBRL Schema -- ci-20200206                           XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
11: ZIP         XBRL Zipped Folder -- 0000950159-20-000034-xbrl      Zip     30K

‘8-K’ — Cigna Corporation Form 8-K

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C: C: C: C: C: C: C:

i 0001739940 i false 0001739940 2020-02-06 2020-02-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) i February 6, 2020

i Cigna Corporation

(Exact name of registrant as specified in its charter)

i Delaware

(State or other jurisdiction of incorporation)

i 001-38769

(Commission File Number)

i 82-4991898

(IRS Employer

Identification No.)

i 900 Cottage Grove Road

i Bloomfield, i Connecticut i 06002

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:

( i 860) i 226-6000

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i [_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i [_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i [_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i [_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock, Par Value $0.01	i CI	i New York Stock Exchange, Inc.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02

Results of Operations and Financial Condition.

On February 6, 2020, Cigna Corporation issued a press release announcing results for the three months and year ended December 31, 2019. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date of this Current Report on Form 8-K, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01	Financial Statements and Exhibits.

(d)	Exhibits.

Exhibit No.	Description

99.1	Press release dated February 6, 2020.

104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Cigna Corporation


Date: February 6, 2020	By:	/s/ *Eric P. Palmer*
		Eric P. Palmer
		Executive Vice President and
		Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	2/6/20	4
	12/31/19	10-K, 11-K
		List all Filings

↑Top

Filing Submission 0000950159-20-000034 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)